Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients

Trial registration ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered

Bibliographic Details
Main Authors: Aijia Ma, Jiangli Cheng, Jing Yang, Meiling Dong, Xuelian Liao, Yan Kang
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Critical Care
Online Access:http://link.springer.com/article/10.1186/s13054-020-03007-0

Internet

http://link.springer.com/article/10.1186/s13054-020-03007-0

Similar Items